Tag: chemotherapy and immunotherapy combination

Three-year follow-up of the phase 3 KEYNOTE-966 trial confirms that adding pembrolizumab to gemcitabine and cisplatin chemotherapy maintains a durable ...

Metastatic gastric cancer remains one of oncology’s most formidable challenges, often delivering devastating prognoses despite decades of research. However, the ...

In a groundbreaking stride toward improving treatment protocols for hormone receptor-positive breast cancer, a new randomized pilot trial has unveiled ...

In the realm of cancer treatment, recent breakthroughs have emerged that could significantly alter the course of therapy for gastric ...

In a groundbreaking phase II clinical trial, researchers are exploring an innovative therapeutic strategy for extensive-stage extrapulmonary small cell carcinoma ...

In recent years, the landscape of non-small cell lung cancer (NSCLC) treatment has undergone a significant transformation, driven primarily by ...

In a groundbreaking advancement for the treatment of stage III locally advanced non-small cell lung cancer (NSCLC), recent research highlights ...

In a groundbreaking advancement in the field of oncology and immunotherapy, researchers have unveiled crucial insights into the immune dynamics ...

In a groundbreaking advancement that could reshape the therapeutic landscape for advanced non-small cell lung cancer (NSCLC), researchers have identified ...

In a comprehensive study focusing on advanced biliary tract cancer, researchers have provided critical insights into treatment outcomes using a ...